Animal (rabbit; photochemical retinal damage model) · PMID 34726859
Retinoprotective effects of Retinalamin studied in an experimental model of photochemical damage to rabbit retinas — VialBase Research
The single strongest study naming Retinalamin directly; anchors the retinoprotection claim on the compound page.
Last updated · 2021 · Suetov AA et al. · Vestn Oftalmol
Key findings
- Retinalamin reduced photochemical damage to rabbit retinas compared with untreated control
- Provides direct, named-compound preclinical evidence of retinoprotection (not class-level extrapolation)
- The strongest in-vivo evidence specifically naming Retinalamin
Retinalamin retinoprotection in a rabbit photochemical-damage model (PMID: 34726859)
Summary
In a rabbit model of photochemical retinal damage, Retinalamin reduced the extent of retinal injury relative to control — direct in-vivo evidence of retinoprotection for the named compound.
Relevance
This is the most decisive piece of evidence for Retinalamin specifically (as opposed to the broader retinal-peptide class), because it names the compound and uses an in-vivo damage model. Still an animal study, not a human trial.
See Also
- Parent compound: Retinalamin